Figlin RA - Search Results

1

Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors.

Patard JJ, Dorey FJ, Cindolo L, Ficarra V, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Belldegrun AS, Pantuck AJ. Patard JJ, et al. Among authors: figlin ra. J Urol. 2004 Dec;172(6 Pt 1):2167-71. doi: 10.1097/01.ju.0000141137.61330.4d. J Urol. 2004. PMID: 15538224

2

Immunotherapy for renal cell carcinoma.

Belldegrun A, Figlin R, Danella J, deKernion J. Belldegrun A, et al. Semin Urol. 1992 Feb;10(1):23-7. Semin Urol. 1992. PMID: 1565900 Review.

3

The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.

Figlin RA, Abi-Aad AS, Belldegrun A, deKernion JB. Figlin RA, et al. Semin Oncol. 1991 Oct;18(5 Suppl 7):102-7. Semin Oncol. 1991. PMID: 1719641 Review.

4

Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.

Abi-Aad AS, Figlin RA, Belldegrun A, deKernion JB. Abi-Aad AS, et al. Among authors: figlin ra. J Immunother (1991). 1991 Aug;10(4):292-5. J Immunother (1991). 1991. PMID: 1931865

5

Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy.

Belldegrun A, Koo AS, Bochner B, Figlin R, deKernion JB. Belldegrun A, et al. Eur Urol. 1990;18 Suppl 2:42-5. doi: 10.1159/000463962. Eur Urol. 1990. PMID: 2226609 No abstract available.

6

Immunologic approaches to the treatment of cancer.

Figlin RA, Gitlitz BJ, Belldegrun A. Figlin RA, et al. Cancer Invest. 1995;13(3):339-40. doi: 10.3109/07357909509094469. Cancer Invest. 1995. PMID: 7743386 No abstract available.

7

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment.

Taneja SS, Pierce W, Figlin R, Belldegrun A. Taneja SS, et al. Urology. 1995 Jun;45(6):911-24. doi: 10.1016/s0090-4295(99)80108-3. Urology. 1995. PMID: 7771023 Review. No abstract available.

8

Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.

Pierce WC, Belldegrun A, Figlin RA. Pierce WC, et al. Among authors: figlin ra. Semin Oncol. 1995 Feb;22(1):74-80. Semin Oncol. 1995. PMID: 7855622 Review. No abstract available.

9

Management of disseminated kidney cancer.

Taneja SS, Pierce W, Figlin R, Belldegrun A. Taneja SS, et al. Urol Clin North Am. 1994 Nov;21(4):625-37. Urol Clin North Am. 1994. PMID: 7974894 Review.

10

Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.

Figlin RA, Pierce WC, Belldegrun A. Figlin RA, et al. Semin Oncol. 1993 Dec;20(6 Suppl 9):11-5. Semin Oncol. 1993. PMID: 8284686 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters